SMP
May 11, 2021 News | Press

SMP advises 1717 Life Science Ventures on sale of shares

Berlin – SMP's Martin Schaper advised 1717 Life Science Ventures on the sale of its stake in drug developer PENTIXAPHARM to Eckert & Ziegler Strahlen- und Medizintechnik AG. In the course of the transaction, Eckert & Ziegler acquired a direct majority stake in PENTIXAPHARM, a joint venture between Scintomics GmbH and 1717 Life Science Ventures GmbH.

SMP had already advised on the establishment of the joint venture in 2019.

With a solid history of building successful radiopharmaceutical startups, the 1717 team has personal experience in all key functions of an early-stage radiopharmaceutical development company. PENTIXAPHARM is developing a radiopharmaceutical combination product for lymphoma and a number of related tumors. Together with an internal transfer, Eckert & Ziegler says it will directly hold around 83% of the shares in the Würzburg-based company after the closing. The management of PENTIXAPHARM, which holds the remaining 17% of PENTIXAPHARM shares, also received put options on the remaining shares as part of the share sale. Further information can be found here.

Advisors 1717 Life Science Ventures GmbH: SMP
Dr. Martin Schaper, Partner

Download Press Realease


About SMP
SMP is a boutique law firm for tax and business law which is active in the core fields of Tax, Funds, Corporate, Litigation and Transactions. The attorneys and tax specialists at SMP represent a broad client base, which ranges from emerging technology companies and family-run SMEs to large corporations as well as private equity and venture capital funds. Founded in 2017, SMP has become one of the leading players for venture capital, private equity and fund structuring in Germany. The firm and its partners have been recognized nationally and internationally by JUVE, Best Lawyers, Legal 500, Focus and Chambers and Partners. Today, SMP has more than 70 experienced lawyers and tax specialists in three Offices in Berlin, Hamburg and Cologne.

Contact:

Holm Krause
Senior Corporate Communications Manager, Berlin Office